Pfizer, CDC experts don’t see eye to eye on COVID-19 boosters, threatening key revenue stream: analysts nhigginsdunn Mon, 06/28/2021 – 15:46 More: Pfizer, CDC experts don't see eye to eye on COVID-19 boosters, threatening key revenue stream: analysts Source: fierce
read moreAstraZeneca posts phase 3 data on once-weekly diabetes drug in adolescents ntaylor Mon, 06/28/2021 – 11:59 More: AstraZeneca posts phase 3 data on once-weekly diabetes drug in adolescents Source: fierce
read moreFDA accepts Roche’s 6-month Lucentis implant for priority review ntaylor Mon, 06/28/2021 – 11:53 More: FDA accepts Roche’s 6-month Lucentis implant for priority review Source: fierce
read moreNovartis says it overpaid Roche’s Genentech nearly $210 million in a licensing deal—and it wants its money back nhigginsdunn Mon, 06/28/2021 – 11:25 More: Novartis says it overpaid Roche's Genentech nearly 0 million in a licensing deal—and it wants its
read moreSanofi offloads 16 consumer health brands to Stada amid CEO Hudson’s refocusing effort fkansteiner Mon, 06/28/2021 – 11:22 More: Sanofi offloads 16 consumer health brands to Stada amid CEO Hudson's refocusing effort Source: fierce
read moreBimzelx inhibits IL-17A and IL-17F, two key cytokines that drive inflammatory processes More: CHMP recommends approval of UCB’s Bimzelx for plaque psoriasis Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals